Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

By A. Palumbo, S. Rajkumar, M. Dimopoulos, P. Richardson, J. Miguel, B. Barlogie, J. Harousseau, J. Zonder, M. Cavo, M. Zangari and 24 more. Leukemia, 2008

827 citations recorded by the source corpus.

Subfields: Hematology, Internal Medicine, Oncology

View Paper: https://www.semanticscholar.org/paper/ad321a01765a7ab84d68f068345494f6a99e142f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. G. Lyman
2. Agnes Y. Y. Lee
3. N. Kuderer
4. J. Arcelus
5. N. Key
6. C. Francis
7. E. Balaban
8. J. Clarke

Citations in the corpus

• Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. (2013, background): “The International Myeloma Working Group proposed a consensus-based risk assessment algorithm to categorize risk among patients with myeloma; validation is awaited.(92) Several VTE risk assessment tools have been developed and validated in the perioperative setting, but none has specifically focused ”